The role of CFTR modulators in the control of ABPA therefore remains to be elucidated; the preliminary evidence suggests a dampened Aspergillus-induced reactive oxygen species production by CF phagocytes in patients treated with ivacaftor alone or in combination with lumacaftor.7 This evidence concerns the gene CFTR and cystic fibrosis.